Clonazepam (Klonopin) Tablet Shortage: FDA Status and Manufacturer Availability Updates
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA reports an ongoing shortage of Clonazepam tablets. While some manufacturers report current availability, the medication remains on the official shortage list.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Clonazepam.
What's in Shortage
Clonazepam tablets, also known by the brand name Klonopin, are currently listed on the FDA drug shortage database. This medication is utilized across several therapeutic categories, including Neurology, Pediatrics, and Psychiatry. The shortage was first posted on March 10, 2023, and was most recently updated on February 3, 2026.
Which Manufacturers Are Affected
According to the latest data, the following manufacturers have specific presentations of the drug available, though the medication remains in an overall shortage status:
Accord Healthcare Inc.
- Status: Available
- Presentations:
- Clonazepam, Tablet, 0.5 mg (NDC 16729-136-00, 16729-136-16)
- Clonazepam, Tablet, 1 mg (NDC 16729-137-00, 16729-137-16)
- Clonazepam, Tablet, 2 mg (NDC 16729-138-00, 16729-138-16)
- Contact: 866-941-7875, option 2
Cheplapharm Arzneimittel GmbH (Marketed by H2-Pharma)
- Status: Available
- Presentations:
- Klonopin, Tablet, 0.5 mg (NDC 61269-605-10)
- Klonopin, Tablet, 1 mg (NDC 61269-610-10)
- Klonopin, Tablet, 2 mg (NDC 61269-620-10)
- Contact: orders@h2-pharma.com
Why There's a Shortage
No specific reason for the shortage was provided in the source data at this time.
What Patients Should Do
If you are prescribed Clonazepam and are experiencing difficulty filling your prescription, consider the following steps:
- Speak with your pharmacist: They can check current stock levels or attempt to order from different distributors.
- Consult your healthcare provider: Discuss your treatment plan and any concerns regarding medication access.
- Contact manufacturers: You may use the contact information provided above to inquire about supply availability in your region.
Disclaimer: Patients should always consult with their healthcare provider regarding their medical treatment and any changes to their medication regimen.
Source
Attribution: FDA Drug Shortage Database
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.